Appointments at Epizyme, Pregis, SixLog, Anthera and Cordis – People on the move
Epizyme has named Robert Gould as its CEO and Jason Rhodes as executive vice president (EVP) and chief business officer. Gould has been on the Epizyme board for two years and has previously worked at the Broad Institute and Merck & Co.
Rhodes joins from Alnylam, where he was VP, business development, and is also a founder of Fidelity Investments’ biotech venture capital group.
Vanessa Valdez has been appointed general manager of SixLog, a company providing biological decontamination services. Valdez has spent the past six years at Astro Pak, SixLog’s parent company, most recently as director of marketing.
Pregis Protective Packaging Europe has named Hamadi Ettarfass as business development director for systems. Ettarfass worked at Ranpak for 12 years.
Georgina Kilfoil has joined Anthera Pharmaceuticals as SVP of product development and clinical operations. Kilfoil has previously worked at InClin and Peninsula Pharmaceuticals.
Semprus BioSciences has appointed Colin Gardner and Michael Cima to its scientific advisory board. Gardner has worked as a consultant and also held positions at TransForm Pharmaceuticals and Merck & Co.
Cima has been involved in operations at MicroChips, Taris Biomedical, Entra Pharmaceuticals, T2 Biosystems and TransForm.
Christian Spaulding has been named worldwide VP of medical affairs at Cordis.
Karo Bio AB has appointed Fredrik Lindgren as president and CEO. Lindgren has previously worked as CEO of Active Biotech AB and Biolin Scientific AB.
